Filter Results
:
(3)
Show Results For
-
All HBS Web
(18)
- Faculty Publications (3)
Show Results For
-
All HBS Web
(18)
- Faculty Publications (3)
Page 1 of
3
Results
- 2024
- Working Paper
Laparoscopy—Minimally Invasive Surgery: Case Histories of Transformational Advances
By: Amar Bhidé, Caitlin N. Bowler and Srikant M. Datar
We describe how operations through laparoscopes – tubular instruments inserted into abdominal cavities – revolutionized gynecological and other surgeries inside the abdomen, such as gall bladder removal. Specifically, we chronicle the 1) foundational contributions of...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation and Invention;
Innovation and Invention;
Governing Rules, Regulations, and Reforms
Bhidé, Amar, Caitlin N. Bowler, and Srikant M. Datar. "Laparoscopy—Minimally Invasive Surgery: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-008, July 2019. (Revised May 2024.)
- February 2019 (Revised October 2019)
- Case
Extend Fertility: Conceiving the Market for Egg Preservation (A)
By: Debora L. Spar and Olivia Hull
In April 2003, entrepreneur and MBA student Christy Jones was planning a new venture to help women preserve their fertility. Her company, Extend Fertility, would commercialize a technique known as egg freezing, in which a woman’s eggs were extracted and stored at low...
View Details
Keywords:
Assisted Reproduction;
Entrepreneur;
Health And Wellness;
Fertility;
Infertility;
Women's Health;
Creating Markets;
Egg Freezing;
Fertility Clinic;
Entrepreneurship;
Strategy;
Marketing Strategy
Spar, Debora L., and Olivia Hull. "Extend Fertility: Conceiving the Market for Egg Preservation (A)." Harvard Business School Case 719-019, February 2019. (Revised October 2019.)
- September 2014
- Case
OvaScience
By: G. Felda Hardymon, Tom Nicholas, Toby Stuart and Noah Fisher
In early April 2012, Michelle Dipp, MD, Ph.D, CEO and co-founder of OvaScience, had just received a buyout offer from PG Ventures, a private equit's first promising fertility treatment, AUGMENT (Autologous Germ-line Mitochondrial Energy Transfer), had the potential to...
View Details
Hardymon, G. Felda, Tom Nicholas, Toby Stuart, and Noah Fisher. "OvaScience." Harvard Business School Case 815-058, September 2014.